Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01103492 · ClinicalTrials.gov registry record · NA

Treatment of Hemorrhagic Radiation Proctitis Using the Halo System

A NA study, sponsored by University Hospitals Cleveland Medical Center.

Completed
Registry status
NA
Development phase
1
Enrollment target

NCT01103492 is a NA study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 1 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01103492, a NA study, has completed, sponsored by University Hospitals Cleveland Medical Center.

COMPLETED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

This study involves evaluating a procedure in which the study device, the HALO90 Ablation catheter, is used to heat a thin layer of tissue lining the rectum using radiofrequency (RF) energy in subjects suffering from radiation proctitis (acute inflammation of the inner lining of the rectum caused by the side effects of radiation treatments that can lead to bleeding). In medical procedures, the RF energy used with this device, has been historically used in shrinking or removing soft-tissue, for surgical cutting, and for stopping bleeding. The device is cleared by the Food and Drug Administration (FDA) for use in coagulation (to assit with stoping bleeding and clotting of blood) of tissue within the digestive tract. The device has been used in areas outside the esophagus (inner lining of the throat), including the rectum to treat radiation proctitis. The stoppage of bleeding of radiation proctitis, using the HALO device, may be one method to control the bleeding. The purpose of this study is to evaluate the effectiveness and record the results of treatment of radiation proctitis using the HALO device.

Interventions

  • DEVICE HALO90 Ablation catheter

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2008-07
Est. Completion 2009-06
Phase NA

What the Registry Record Tells You About NCT01103492

The ClinicalTrials.gov registry entry for NCT01103492 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which HALO90 Ablation catheter is the first listed.

NCT01103492 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01103492 about?

NCT01103492 is a clinical study titled "Treatment of Hemorrhagic Radiation Proctitis Using the Halo System". This study involves evaluating a procedure in which the study device, the HALO90 Ablation catheter, is used to heat a thin layer of tissue lining the rectum using radiofrequency (RF) energy in subjects suffering from radiation proctitis (acute inflammation of the inner lining of the rectum caused by...

What is the current status of trial NCT01103492?

This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2008-07. Estimated completion is 2009-06.

What interventions are being tested in trial NCT01103492?

The interventions under investigation include: HALO90 Ablation catheter (DEVICE).

Who is sponsoring clinical trial NCT01103492?

This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.